Advancement in New Drug Discovery for Treatment of Hepatitis

  • Sofosbuvir plus simeprevir for genotype 1 chronic hepatitis C infection
  • Sofosbuvir for genotype 2 and 3 chronic hepatitis C infection
  • Ribavirin for chronic hepatitis E infection in transplant recipients

Related Conference of Advancement in New Drug Discovery for Treatment of Hepatitis

June 18-20, 2018

6th World Congress on Hepatitis & Liver Diseases

Dublin, Ireland
June 28-30, 2018

Euro Global Congress on HCV

Amsterdam, Netherlands
June 25-27, 2018

14th World Congress on Gastroenterology and Hepatology

Stockholm, Sweden
August 6-7, 2018

14th Annual Congress on Gastroenterology & Hepatology

Hyatt Regency Osaka, Japan
August 20-21, 2018

13th Euro-Global Gastroenterology Conference

Rome, Italy
September 7-8, 2018

18th World Gastroenterologists Summit

Auckland, New Zealand
September 12-13, 2018

World Summit on Liver Cirrhosis and Hepatitis

Singapore
September 17-18, 2018
10 Plenary Forums - 1Event

3rd International Conference on Hepatobiliary & Pancreatic Disorders

Philadelphia, Pennsylvania, USA
September 21-22, 2018

6th International Conference on Hepatology

Osaka, Japan
October 15-16, 2018

3rd World Liver Congress

Abu Dhabi, UAE
October 29-30, 2018

4th World Congress on Digestive & Metabolic Diseases

| San Francisco, California, USA
October 29-30,2018

18th International Conference on Gastroenterology and Endoscopy

San Francisco, California, USA
November 08-09, 2018

15th World Congress on Gastroenterology & Therapeutics

Auckland, Newzealand
March 04-06, 2019

20th World Congress on Gastroenterology

Berlin, Germany

Advancement in New Drug Discovery for Treatment of Hepatitis Conference Speakers